Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Lung Cancer News ••• Topics • Countries • U.S. States

Lung Cancer Metastasis News Monitoring

Get by Email • RSS

Published on Mar 7, 2025

Teddi Mellencamp says scans reveal multiple brain and lung tumors after her surgery

Teddi Mellencamp, former star of "The Real Housewives of Beverly Hills" and daughter of singer John Mellencamp, has revealed that recent scans show she still has multiple tumors in her brain that were not able to be removed by surgery, and tumors …

Source: NBC News - Center-left
Published on Mar 7, 2025

Plus Therapeutics Gets FDA Orphan Drug Status for Obisbemeda in Lung Cancer

Plus Therapeutics, Inc. announces that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Rhenium (186Re) Obisbemeda for the treatment of leptomeningeal metastases (LM) in patients with lung cancer. “Receiving Orphan …

Source: Pharma Journalist - Neutral
Published on 12:00 GMT

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using ...

SAN DIEGO, March 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced promising preclinical …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on 13:48 GMT

Rising Prevalence Of Nasopharyngeal Carcinoma, Its Market Implications: A Key Driver Transforming The Loqtorzi Market

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! LONDON, GREATER LONDON, UNITED KINGDOM, March 10, 2025 /⁨EINPresswire.com⁩/ -- How Has the Loqtorzi Market Performed in Recent Years? • …

Distribution channels: Business & Economy, Companies ...
Published on Mar 6, 2025

Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell ...

Trial to explore novel combination therapy for patients with recurrent Small Cell Lung Cancer who have failed frontline treatment Fully funded by the U.S. Veterans’ Administration Special Emphasis Panel on Precision Oncology Trial builds on promising …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on Mar 6, 2025

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of ...

HOUSTON, March 06, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company” or “Plus Therapeutics”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on Mar 5, 2025

Study Explores Immunotherapy vs. Chemoimmunotherapy Decisions For Advanced Non-Small Lung Cancer

In treating advanced non-small cell lung cancer (aNSCLC), the choice between immunotherapy alone and chemoimmunotherapy (a combination of chemotherapy with the newer immunotherapy agents) depends on several factors. Clinical guidelines typically do not …

Source: Managed Healthcare Executive - Neutral
Published on Mar 7, 2025

Examining the Outcomes of Palliative Oophorectomy of Ovarian Metastases in de-Novo Metastatic Colorectal Cancer and Its ...

Introduction Colorectal cancer (CRC) is the third most common malignancy worldwide, accounting for over 1.85 million new cases and 850 000 deaths each year, making it the second in terms of mortality.1 Of those newly diagnosed with colorectal cancer, 20% …

Source: Dove Medical Press - Neutral
Published on Mar 5, 2025

Nogapendekin Alfa Inbakicept/CAR-NK Wins FDA RMAT Designation for Lymphopenia Reversal in Metastatic Pancreatic Cancer

The FDA has granted nogapendekin alfa inbakicept-pmln (Anktiva) and CAR-NK (PD-L1 t-haNK) regenerative medicine advanced therapy (RMAT) designation for the reversal of lymphopenia in patients treated with standard of care (SOC) chemotherapy/ …

Source: OncLive - Label Pending
Published on Mar 8, 2025

Jurassic-era trees have grown in Tasmania for millions of years. Now they face their biggest threat: fire

Steve Leonard finds it hard when he goes bushwalking in Tasmania’s high country these days. “I look at a stand of pencil pine and I wonder: ‘how long will you be there?’” The ecologist is just back from a rapid survey of the cost to ancient trees of the …

Source: The Guardian - Center-left
Published on Mar 8, 2025

Rezivertinib Improves PFS vs Gefitinib in EGFR-Mutant NSCLC

Rezivertinib (BPI-7711) elicited improved efficacy and progression-free survival (PFS) with no new safety signals compared with gefitinib (Iressa) in patients with locally advanced or metastatic non–small cell lung cancer (NSCLC) harboring an EGFR mutation …

Source: Cancer Network - New Jersey - Label Pending
Published on Mar 8, 2025

Why the Global Cancer Market Could Surpass $900 Billion–And the Stocks Leading the Charge

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, March 8, 2025 /PRNewswire/ — As the global cancer crisis intensifies, the demand for breakthrough treatments is reaching new heights. Statista data projects a …

Source: The AI Journal - Label Pending
Published on Mar 8, 2025

Global Enhertu Market Forecast: Key Growth Drivers, Trends, And Opportunities From 2025 To 2034

Enhertu Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 8, 2025 /⁨EINPresswire.com⁩/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase …

Distribution channels: Business & Economy, Companies ...
Published on Mar 8, 2025

AstraZeneca announces positive results from MATTERHORN phase III trial of Imfinzi in combo with standard─of─care FLOT in ...

Positive high-level results from the MATTERHORN phase III trial showed perioperative treatment with AstraZeneca’s Imfinzi (durvalumab) in combination with standard-of-care FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) chemotherapy …

Source: Pharmabiz.com - Neutral
Published on Mar 8, 2025

5 Things to Know About Colorectal Cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the US, but it doesn’t have to be.1 With early detection and proactive lifestyle choices, many cases are preventable or treatable. However, cases are rising among younger …

Source: The American Journal of Managed Care - Neutral
Published on Mar 8, 2025

Rose Mary Martin

December 5, 1936 — March 4, 2025 Shawnee, Kansas Rose Mary Martin was born on December 5, 1936, to William F. Baldwin and Bertha F. Baldwin (Bird) in Kansas City, MO. Growing up during World War II, Rose Mary became known as America’s War Child when …

Source: Prairie Village Post - Kansas - Neutral
Published on Mar 8, 2025

FDA Clears Phase 1 Trial of MRANK-106 in Advanced Solid Tumors

The FDA has cleared the investigational new drug (IND) application for MRANK-106, a first-in-class dual WEE1/YES1 kinase inhibitor for advanced solid tumors. Preclinical data show superior efficacy, reduced hematotoxicity, and broad activity in …

Source: Targeted Oncology - Label Pending
Published on Mar 8, 2025

Palliative Psychiatry and Assisted Suicide for Mental Illness: Not 1 and the Same

We read with great interest Karandeep Sonu Gaind, MD's commentary, “‘Palliative Psychiatry’ and Assisted Suicide: Compassion? Abandonment? Or Something Far Worse?” However, we take issue with Gaind’s mischaracterization of palliative psychiatry. …

Source: Psychiatric Times - New Jersey - Label Pending
Published on Mar 8, 2025

The Effect of Dato-DXd Targeting TROP2 in Urothelial Cancer

During the 2025 ASCO Genitourinary Cancer Symposium, CancerNetwork® spoke with Funda Meric-Bernstam, MD, the chair of the Department of Investigational Cancer Therapeutics-the Phase 1 Program, medical director of the Institute for Personalized Cancer …

Source: Cancer Network - New Jersey - Label Pending

07 days 11:25:40

Featured Releases

Got News to Share? · Submit · See All

Published on March 10, 2025 - 13:48 GMT

Top Driver Transforming The Libtayo Market 2025: Rising Prevalence of Acute Leukemia is Driving the Market Growth

Updated 2025 Market Reports have released and offer essential trends and forecasts up to 2034. Early purchase is your competitive edge! LONDON, GREATER LONDON, UNITED KINGDOM, March 10, 2025 /⁨EINPresswire.com⁩/ -- How Has the Libtayo Market …

Distribution channels: Business & Economy, Companies ...
Published on March 10, 2025 - 13:48 GMT

Rising Prevalence Of Nasopharyngeal Carcinoma, Its Market Implications: A Key Driver Transforming The Loqtorzi Market

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! LONDON, GREATER LONDON, UNITED KINGDOM, March 10, 2025 /⁨EINPresswire.com⁩/ -- How Has the Loqtorzi Market Performed in Recent Years? • …

Distribution channels: Business & Economy, Companies ...

Published on March 10, 2025 - 12:00 GMT

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using ...

SAN DIEGO, March 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced promising preclinical …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on March 10, 2025 - 10:55 GMT

BioNTech veröffentlicht Ergebnisse für das vierte Quartal und das Geschäftsjahr 2024 sowie Informationen zur Geschä...

Onkologie-Pipeline weiterentwickelt mit mehr als 20 aktiven klinischen Phase-2- und Phase-3-Studien mit strategischem Fokus auf zwei tumorübergreifende (Pan-Tumor-)Programme: Immunmodulator-Kandidat BNT327 und mRNA-Krebsimmuntherapie-Kandidaten Zahlreiche …

Distribution channels: Business & Economy, Media, Advertising & PR ...

Published on March 10, 2025 - 10:55 GMT

BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update

Advanced oncology pipeline including more than 20 active Phase 2 and Phase 3 clinical trials with a strategic focus on two priority pan-tumor programs: next-generation immunomodulator candidate BNT327 and mRNA cancer immunotherapies Multiple data readouts …

Distribution channels:
Published on March 6, 2025 - 13:00 GMT

Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell ...

Trial to explore novel combination therapy for patients with recurrent Small Cell Lung Cancer who have failed frontline treatment Fully funded by the U.S. Veterans’ Administration Special Emphasis Panel on Precision Oncology Trial builds on promising …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on March 6, 2025 - 12:30 GMT

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of ...

HOUSTON, March 06, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company” or “Plus Therapeutics”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 10, 2025 - 16:10 GMT

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU IVDR1, expanding the eligibility of treatment to early-stage non-small cell lung cancer (NSCLC) and …

Distribution channels:

Got news to share? Submit it now.

Load more lung cancer news or search news using your own keywords. There are 792,388,146 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Lung Cancer News by Country

Lung Cancer News by U.S. State

Lung Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 02/17/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on March 10, 2025 - 16:09 GMT

Image Intensifier Market Expected to Witness Sustainable Growth Over 2031

Image Intensifier Market Expected to Reach $3.2 Billion by 2031 — Allied Market Research WILMINGTON, DE, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- The global image intensifier market share is expected to witness considerable growth, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on March 10, 2025 - 16:07 GMT

Acclaimed Eye Surgeon Dr. James Kelly Welcomes Award-Winning Ophthalmologist Dr. Ashley Brissette to Kelly Vision

NEW YORK , NY, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- Today Dr. James Kelly, Founder of Kelly Vision, is proud to announce and welcome Ophthalmologist Ashley Brissette MD, MSC, FRCSC to Kelly Vision. With the unveiling of the new, …

Distribution channels: Beauty & Hair Care, Healthcare & Pharmaceuticals Industry ...
Published on March 10, 2025 - 15:56 GMT

Super Brush LLC to Exhibit Innovative Foam Swabs at Forum Labo Paris 2025

US-based foam swab manufacturer Super Brush LLC is excited to announce its participation in Forum Labo Paris 2025 SPRINGFIELD, MA, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- US-based foam swab manufacturer Super Brush LLC is excited to …

Distribution channels: Beauty & Hair Care, Business & Economy ...
Published on March 10, 2025 - 15:53 GMT

Key Market Driver In Pedvaxhib Industry 2025: Increasing Immunization Initiatives Globally Fuel Market

The Business Research Company's Key Market Driver In Pedvaxhib Industry 2025: Increasing Immunization Initiatives Globally Fuel Market LONDON, GREATER LONDON, UNITED KINGDOM, March 10, 2025 /⁨EINPresswire.com⁩/ -- Updated 2025 Market Reports …

Distribution channels: Business & Economy, Emergency Services ...
Published on March 10, 2025 - 15:53 GMT

Global Oxlumo Market Forecast: Key Growth Drivers, Trends, And Opportunities From 2025 To 2034

The Business Research Company's Global Oxlumo Market Forecast: Key Growth Drivers, Trends, And Opportunities From 2025 To 2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 10, 2025 /⁨EINPresswire.com⁩/ -- Updated 2025 Market Reports Released: …

Distribution channels: Business & Economy, Emergency Services ...
Published on March 10, 2025 - 15:30 GMT

UV Blood Irradiation: Patients Medical in NYC Introduces Revolutionary Treatment for Chronic Illness

UV Blood Irradiation, involves exposing a small amount of the patient's blood to ultraviolet light and enhancing their ability to fight off infections NEW YORK, NY, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- Patients Medical, a leading …

Distribution channels: Agriculture, Farming & Forestry Industry, Chemical Industry ...
Published on March 10, 2025 - 15:29 GMT

Global Pancreaze (Pancrelipase) Market Insights 2025: Key Trends, Market Size, And Growth Forecast

The Business Research Company's Global Pancreaze (Pancrelipase) Market Insights 2025: Key Trends, Market Size, And Growth Forecast LONDON, GREATER LONDON, UNITED KINGDOM, March 10, 2025 /⁨EINPresswire.com⁩/ -- Updated 2025 Market Reports …

Distribution channels: Business & Economy, Emergency Services ...
Published on March 10, 2025 - 15:28 GMT

Top Growth Driver In The Padcev Market 2025: Growing Incidence Of Bladder Cancer Fuels Growth

The Business Research Company's Top Growth Driver In The Padcev Market 2025: Growing Incidence Of Bladder Cancer Fuels Growth LONDON, GREATER LONDON, UNITED KINGDOM, March 10, 2025 /⁨EINPresswire.com⁩/ -- Updated 2025 Market Reports Released: …

Distribution channels: Business & Economy, Emergency Services ...
Published on March 10, 2025 - 15:00 GMT

Blackford partners with the American College of Radiology’s Assess-AI Registry for AI Performance Benchmarking

Assess-AI delivers key insights on AI performance in radiology, ensuring reliability, supporting adoption, and helping clinicians improve patient care. EDINBURGH, UNITED KINGDOM, March 10, 2025 /⁨EINPresswire.com⁩/ -- Blackford, the pioneering …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on March 10, 2025 - 14:59 GMT

Full Circle Coaching Invests $78,000 to Launch ‘NextGen Chiropractic Coaching Scholarship’ for Chiropractic Future

Full Circle Coaching launches the NextGen Chiropractic Coaching Scholarship, committing $78K to mentor young chiropractors and ensure the future of care. NORTH BAY, ONTARIO, CANADA, March 10, 2025 /⁨EINPresswire.com⁩/ -- Chiropractic care is more than a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 10, 2025 - 14:53 GMT

Sustainable Packaging Market Set for Significant Expansion with Rising Demand Through 2031

Using sustainable packaging methods like modified atmosphere packaging can make food last longer. It also cuts down on food waste. WILMINGTON, DE, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- Sustainable Packaging Market - Sustainable …

Distribution channels: Food & Beverage Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 10, 2025 - 14:32 GMT

National Personal Trainer Certification Course - NCCA Accredited

This collegiate hybrid program has virtual LIVE Lectures & In-person Practical Skill labs for long term career success! VIRGINIA BEACH, VA, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- W.I.T.S. offers collegiately based certification …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 10, 2025 - 14:20 GMT

Cytokine Market Projected To Witness Substantial Growth, 2025-2032:Abbott, AB Sciex, Agilent Technologies, bioMerieux SA

The cytokine market is estimated to be valued at USD 98.84 Bn in 2025 and is expected to reach USD 178.50 Bn by 2032, exhibiting CAGR of 8.8% from 2025 to 2032. BURLINGAME, CA, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- The Latest …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 10, 2025 - 14:18 GMT

Disinfectant Robot Market Projected To Witness Substantial Growth, 2025-2032: Time Medical Holding Robotics, Blue Ocean

Global disinfectant robot market is estimated to be valued at USD 1.65 Bn in 2025 and is expected to reach USD 7.87 Bn by 2032, exhibiting CAGR of 25.0%. BURLINGAME, CA, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- The Latest …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 10, 2025 - 14:17 GMT

H2Ocean’s Outstanding Participation at the 3rd International Conference on Cancer Research at UTRGV School of Medicine

Sea salt based innovations & research showcased at UTRGV’s Cancer Health Disparities Conference, highlighting its significant role in cancer survivorship. STUART, FL, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- H2Ocean, a global leader in …

Distribution channels: Business & Economy, Conferences & Trade Fairs ...
Published on March 10, 2025 - 14:16 GMT

Protein Engineering Market Projected To Witness Substantial Growth, 2025-2032: Agilent Technologies Inc., Amgen Inc

Protein Engineering Market is estimated to be valued at USD 4.21 Billion in 2025 and is expected to reach USD 12.26 Billion by 2032, growing at a CAGR of 16.5%. BURLINGAME, CA, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- The Latest …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 10, 2025 - 14:12 GMT

Single-Use Bioreactor Market Projected To Witness Substantial Growth, 2025-2032: Sartorius Stedim Biotech, Merck KgaA

BURLINGAME, CA, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- The Global Single-Use Bioreactor Market is expected to grow at CAGR 17.50% from 2025 to 2032. The Latest comprehensive Research Report on the Single-Use Bioreactor Market …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 10, 2025 - 14:11 GMT

Global Automated External Defibrillator Market Projected To Witness Substantial Growth, 2025-2032: CU Medical System Inc

BURLINGAME, CA, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- The Global Automated External Defibrillator Market is expected to grow at CAGR 9.7% from 2025 to 2032. The Latest comprehensive Research Report on the Automated External …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 10, 2025 - 14:09 GMT

Robotimize Announces Formation of Its Scientific Advisory Board to Drive Innovation in Neurorehabilitation Robotics

Singapore’s Robotimize Group unveils its world-class Scientific Advisory Board to drive breakthrough innovation in neurorehabilitation robotics. SINGAPORE, March 10, 2025 /⁨EINPresswire.com⁩/ -- Robotimize Group, a global leader in …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 10, 2025 - 14:06 GMT

Global Sustained Release Coating Market Projected To Witness Substantial Growth, 2025-2032: Evonik, BASF SE, Colorcon

BURLINGAME, CA, UNITED STATES, March 10, 2025 /⁨EINPresswire.com⁩/ -- The Global Sustained Release Coating Market is expected to grow at CAGR 6.9% from 2025 to 2032. The Latest comprehensive Research Report on the Sustained Release Coating …

Distribution channels: Healthcare & Pharmaceuticals Industry ...